Los Angeles, CA, United States of America

Gal Bitan

This inventor holds 5 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: University of California, Fondazione Telethon Ets, Marine Biological Laboratory. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gal Bitan. Retrieved from https://idiyas.com/inventor/gal-bitan-vx9avq6k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 60.0

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Culver City, CA (US) (2021)
  • Los Angeles, CA (US) (2013 - 2024)
  • Encino, CA (US) (2024)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gal Bitan: Innovator in Molecular Therapeutics

Introduction

Gal Bitan is a prominent inventor based in Los Angeles, CA, known for his significant contributions to the field of molecular therapeutics. With a total of five patents to his name, he has focused on addressing critical health challenges related to lipofuscin aggregation and lysosomal storage disorders. His work reflects a commitment to developing innovative solutions for complex medical issues.

Latest Patents

Among Gal Bitan's latest patents are:

1. **Inhibition of lipofuscin aggregation by molecular tweezers** - This patent presents methods for the treatment and/or prophylaxis of lipofuscin-related disorders. The various embodiments involve administering an effective amount of molecular tweezers to a subject in need.

2. **Treatment of lysosomal storage disorders** - This patent outlines methods for treating or preventing lysosomal storage diseases, incorporating the administration of molecular tweezers that inhibit protein aggregation for affected subjects.

Career Highlights

Gal Bitan has had an impactful career, working with esteemed institutions such as the University of California and Fondazione Telethon Ets. His work in these organizations has allowed him to refine his innovative approaches and contribute to significant advancements in his field.

Collaborations

Throughout his career, Gal has collaborated with prominent colleagues, including Thomas Schrader and Sharmistha Sinha. These partnerships have enhanced his research and helped propel his inventions to new heights.

Conclusion

Gal Bitan's dedication to innovation in molecular therapeutics has led to meaningful advancements in treating and preventing disorders related to lipofuscin and lysosomal storage. With his five patents and collaborative spirit, he continues to be a notable figure in the landscape of contemporary medical research. His work exemplifies how targeted inventions can pave the way for better health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…